Home LiteratureArticle Details
PMID: 12707345 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

Endogenous IL-17 as a mediator of neutrophil recruitment caused by endotoxin exposure in mouse airways.

Journal of immunology (Baltimore, Md. : 1950) ·Vol. 170 ·No. 9 ·2003-05-01 ·Pages 4665-72

Miyamoto M, Prause O, Sjöstrand M, Laan M, Lötvall J, Lindén A

Abstract

We have previously demonstrated that administration of the recently described cytokine IL-17 in rat airways in vivo recruits and activates neutrophils locally. In the current study, we examined whether endogenous IL-17 is involved in mediating neutrophil recruitment caused by endotoxin exposure in mouse airways. Our in vivo data show that local endotoxin exposure causes the release of free, soluble IL-17 protein 6 h later. Systemic pretreatment with a neutralizing anti-IL-17 Ab almost completely inhibits neutrophil recruitment 24 h, but not 6 h, after endotoxin exposure in the airways. Pretreatment with neutralizing anti-IL-6 and anti-macrophage inflammatory protein (MIP)-2 Abs inhibits neutrophil recruitment caused by local endotoxin exposure and IL-17, respectively. Our in vitro data show that endotoxin exposure stimulates the release of soluble IL-17 protein in T lymphocytes harvested from lung and spleen, respectively, and that this cytokine release requires coculture with airway macrophages. Intracellular IL-17 protein is detected in T lymphocytes from spleen but not in airway macrophages after coculture and stimulation of these two cell types. Finally, anti-IL-17 does not alter endotoxin-induced release of IL-6 and MIP-2 from T lymphocytes and airway macrophages in coculture. In conclusion, our results indicate that endotoxin exposure causes the release of IL-17 from T lymphocytes and that this cytokine release requires the presence of macrophages. Once released, endogenous IL-17 acts in part by inducing local release of neutrophil-mobilizing cytokines such as IL-6 and MIP-2, from nonlymphocyte, nonmacrophage cells, and this contributes to recruitment of neutrophils in the airways. These IL-17-related mechanisms constitute potential targets for pharmacotherapy against exaggerated neutrophil recruitment in airway disease.

MeSH Terms
Administration, Intranasal Animals Antibodies, Monoclonal/administration & dosage Bronchoalveolar Lavage Fluid/cytology,immunology Chemokine CXCL2 Dose-Response Relationship, Immunologic Inflammation/blood,immunology Inflammation Mediators/analysis,antagonists & inhibitors,immunology,physiology Injections, Intraperitoneal Interleukin-17/analysis,antagonists & inhibitors,immunology,physiology Interleukin-6/antagonists & inhibitors,metabolism Lipopolysaccharides/administration & dosage Lung/immunology,pathology Male Mice Mice, Inbred C57BL Monokines/antagonists & inhibitors,metabolism Neutrophil Infiltration/immunology Neutrophils/immunology,metabolism,pathology Solubility T-Lymphocytes/immunology,metabolism
Chemicals
Antibodies, Monoclonal Chemokine CXCL2 Inflammation Mediators Interleukin-17 Interleukin-6 Lipopolysaccharides Monokines
Authors & Affiliations
6 authors, click to expand affiliations / ORCID
Miyamoto Masahide
Lung Pharmacology Group, Department of Respiratory Medicine and Allergology, Institute of Internal Medicine, Göteborg University, Gothenburg, Sweden.
Prause Olof
Sjöstrand Margareta
Laan Martti
Lötvall Jan
Lindén Anders
Article Info
Journal
Journal of immunology (Baltimore, Md. : 1950)
Abbr.
J Immunol
ISSN
0022-1767
Published
2003-05-01
Pages
4665-72
Language
English
Region
United States
NLM ID
2985117R
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com